| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Françoise Dignat-George | Q61874319 |
| P2093 | author name string | F Sabatier | |
| J Sampol | |||
| F Dignat-George | |||
| F Anfosso | |||
| L Camoin-Jau | |||
| P2860 | cites work | Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. | Q52538187 |
| Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. | Q53477806 | ||
| Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. | Q53576448 | ||
| Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. | Q53649090 | ||
| Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. | Q53662576 | ||
| Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. | Q53665036 | ||
| Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. | Q54585988 | ||
| Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction | Q57589498 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques | Q58150410 | ||
| Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function | Q58230259 | ||
| Increasing physical education in high school students: effects on concentration of circulating endothelial progenitor cells | Q58327103 | ||
| Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk | Q58419226 | ||
| Increased Ratio of CD31 + /CD42 − Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia | Q58419259 | ||
| End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells | Q60182282 | ||
| The Increase of Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke Is Associated With Good Outcome | Q60589474 | ||
| CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure | Q61403155 | ||
| A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study | Q61965075 | ||
| Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis | Q62395188 | ||
| Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors | Q62590334 | ||
| Measuring circulating cell-derived microparticles | Q62977671 | ||
| Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients | Q63915194 | ||
| Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty | Q68178230 | ||
| Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody | Q70169676 | ||
| High levels of circulating endothelial microparticles in patients with acute coronary syndromes | Q73502484 | ||
| Circulating activated endothelial cells in sickle cell anemia | Q73884398 | ||
| Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis | Q75201497 | ||
| Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation | Q75235829 | ||
| Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells | Q77363585 | ||
| Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis | Q78840682 | ||
| Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 | ||
| Circulating endothelial cells in pulmonary hypertension | Q79092357 | ||
| Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis | Q24294832 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Endothelial progenitor cells in cardiovascular disorders | Q28288695 | ||
| Working hypothesis to redefine endothelial progenitor cells | Q28295515 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting | Q30320636 | ||
| Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia | Q30760797 | ||
| Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor | Q30829120 | ||
| Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin | Q31144359 | ||
| Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia | Q33240375 | ||
| Clinical assessment of endothelial dysfunction: combine and rule | Q33260977 | ||
| Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study | Q33302128 | ||
| Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation | Q33357738 | ||
| Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy | Q33372733 | ||
| Circulating microparticles: pathophysiology and clinical implications. | Q33373336 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Circulating endothelial cells and vascular injury in systemic lupus erythematosus | Q34108825 | ||
| Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals | Q34575418 | ||
| Anoikis in the cardiovascular system: known and unknown extracellular mediators | Q35556526 | ||
| Endothelial progenitor cells for postnatal vasculogenesis | Q35861865 | ||
| Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? | Q35868133 | ||
| Endothelial cell diversity revealed by global expression profiling | Q35977148 | ||
| Mobilizing endothelial progenitor cells | Q36012003 | ||
| Circulating endothelial cells: realities and promises in vascular disorders | Q36030562 | ||
| Circulating endothelial cells in vasculitis and transplantation | Q36030566 | ||
| Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. | Q36355606 | ||
| Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease | Q36519690 | ||
| Circulating endothelial cells: a novel marker of endothelial damage | Q36534332 | ||
| CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells | Q46745585 | ||
| Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension | Q46836578 | ||
| Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes | Q46883062 | ||
| Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. | Q46929685 | ||
| Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties | Q46986573 | ||
| Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients | Q46988956 | ||
| Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation | Q47360467 | ||
| Circulating CD34-positive cells provide an index of cerebrovascular function | Q47377874 | ||
| Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure | Q47449596 | ||
| Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes | Q47835134 | ||
| Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. | Q48028694 | ||
| Circulating endothelial progenitor cells in congestive heart failure | Q48385575 | ||
| Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome | Q48536084 | ||
| Activated protein C induces the release of microparticle-associated endothelial protein C receptor | Q48832607 | ||
| The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. | Q51168559 | ||
| The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting. | Q51186454 | ||
| Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. | Q51525506 | ||
| Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. | Q51798492 | ||
| Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. | Q51949397 | ||
| Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. | Q52094951 | ||
| Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid Communication | Q79129358 | ||
| Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men | Q79421936 | ||
| Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas | Q79568560 | ||
| Endothelial progenitor cells are mobilized after cardiac surgery | Q79674660 | ||
| Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome | Q79826484 | ||
| Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors | Q79827338 | ||
| Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes | Q79843154 | ||
| Endothelial microparticles correlate with endothelial dysfunction in obese women | Q79844450 | ||
| Circulating endothelial progenitor cells predict coronary artery disease severity | Q79849862 | ||
| Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke | Q80156994 | ||
| Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria | Q80166801 | ||
| Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease | Q80219802 | ||
| Effects of treatment for diabetes mellitus on circulating vascular progenitor cells | Q80313200 | ||
| Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide | Q80557623 | ||
| Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes | Q80557646 | ||
| Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes | Q80735257 | ||
| Circulating endothelial cells. Biomarker of vascular disease | Q81402646 | ||
| Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease | Q81432945 | ||
| Circulating endothelial cells in acute ischaemic stroke | Q81443599 | ||
| More on: Measuring circulating cell-derived microparticles | Q81479322 | ||
| Endothelial progenitor cells are reduced in refractory hypertension | Q81574413 | ||
| Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes | Q81641954 | ||
| Kidney graft function determines endothelial progenitor cell number in renal transplant recipients | Q81681919 | ||
| Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism | Q81701125 | ||
| Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress | Q81724759 | ||
| Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease | Q81802705 | ||
| Circulating procoagulant microparticles in obesity | Q82757597 | ||
| Comparative analysis of methods for assessment of circulating endothelial progenitor cells | Q82886120 | ||
| Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis | Q83168031 | ||
| Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease | Q83321296 | ||
| Procoagulant microparticles: disrupting the vascular homeostasis equation? | Q36600785 | ||
| Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases | Q36603898 | ||
| The multifaceted circulating endothelial cell in cancer: towards marker and target identification. | Q36621435 | ||
| Circulating endothelial cells in cardiovascular disease | Q36625620 | ||
| Phenotypic heterogeneity of the endothelium: II. Representative vascular beds | Q36726076 | ||
| Plasma microparticles and vascular disorders | Q36759589 | ||
| Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. | Q36763667 | ||
| Endothelial progenitor cells in health and atherosclerotic disease | Q36799382 | ||
| Endothelial function and hypertension | Q36843763 | ||
| Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors | Q36855640 | ||
| Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. | Q36951208 | ||
| Endothelial precursor cells | Q36961234 | ||
| Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. | Q37076991 | ||
| A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood | Q37201827 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro | Q40112496 | ||
| Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses. | Q40205801 | ||
| Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. | Q40276225 | ||
| Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease | Q40379249 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease | Q40422877 | ||
| Circulating endothelial cells are associated with future vascular events in hemodialysis patients. | Q40447600 | ||
| Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis | Q40646486 | ||
| Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity | Q40732139 | ||
| In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. | Q40851071 | ||
| Biomechanical activation: an emerging paradigm in endothelial adhesion biology. | Q41669887 | ||
| Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis | Q42199433 | ||
| Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells | Q42855929 | ||
| Modulation of endothelial cell activation in sickle cell disease: a pilot study | Q43550991 | ||
| Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy | Q43607198 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Type 1 and type 2 diabetic patients display different patterns of cellular microparticles | Q44114915 | ||
| Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure | Q44270472 | ||
| Elevated numbers of circulating endothelial cells in renal transplant recipients. | Q44514900 | ||
| Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. | Q44670183 | ||
| Endothelium-derived microparticles impair endothelial function in vitro | Q44836488 | ||
| Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers | Q44932451 | ||
| Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c | Q45231089 | ||
| Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production | Q46083601 | ||
| Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. | Q46313514 | ||
| Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. | Q46464366 | ||
| Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans | Q46468933 | ||
| Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. | Q46562569 | ||
| Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. | Q46629217 | ||
| Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension | Q46659628 | ||
| Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension | Q46691696 | ||
| Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure | Q46726712 | ||
| P433 | issue | 3 | |
| P921 | main subject | endothelium | Q111140 |
| circulatory system | Q11068 | ||
| cell | Q7868 | ||
| cell-derived microparticles | Q70311240 | ||
| P304 | page(s) | 454-471 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence | |
| P478 | volume | 13 |
| Q60918030 | Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases |
| Q53137736 | Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction. |
| Q37780630 | Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury |
| Q37941914 | Biomarkers of endothelial cell activation: candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals |
| Q33690900 | CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility. |
| Q37739010 | Cell-based methods for ex vivo evaluation of human endothelial biology. |
| Q38261420 | Central role of eNOS in the maintenance of endothelial homeostasis |
| Q48316365 | Challenging the great vascular wall: Can we envision a simple yet comprehensive therapy for stroke? |
| Q33416860 | Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study. |
| Q35067553 | Circulating endothelial cells in patients with venous thromboembolism and myeloproliferative neoplasms |
| Q34769618 | Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening |
| Q51127792 | Circulating endothelial cells, circulating endothelial progenitor cells, and von Willebrand factor in pregnancies complicated by hypertensive disorders. |
| Q41712425 | Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance |
| Q48230021 | Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q57767331 | Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease |
| Q44284155 | Decreased levels and function of circulating endothelial progenitor cells in unruptured intracranial saccular aneurysm patients |
| Q55052510 | Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. |
| Q92132640 | Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation |
| Q45981560 | Dietary flavanol intervention lowers the levels of endothelial microparticles in coronary artery disease patients. |
| Q90535685 | Downregulated GTCPH I/BH4 Pathway and Decreased Function of Circulating Endothelial Progenitor Cells and Their Relationship with Endothelial Dysfunction in Overweight Postmenopausal Women |
| Q34420360 | Early endothelial damage detected by circulating particles in baboons fed a diet high in simple carbohydrates in conjunction with saturated or unsaturated fat. |
| Q46814261 | Effect of uraemia on endothelial cell damage is mediated by the integrin linked kinase pathway |
| Q36719448 | Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial |
| Q33813731 | Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy |
| Q38707419 | Endothelial Repair and Regeneration Following Intimal Injury |
| Q42250251 | Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools |
| Q36307560 | Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema |
| Q90871287 | Endothelium structure and function in kidney health and disease |
| Q33578948 | Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers |
| Q90086150 | Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China |
| Q34514940 | Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy |
| Q99239920 | Extracellular Vesicle-Related Thrombosis in Viral Infection |
| Q39107240 | Extracellular vesicles and blood diseases |
| Q38601736 | Extracellular vesicles as immune mediators in response to kidney injury |
| Q38260393 | Growth factor- and cytokine-stimulated endothelial progenitor cells in post-ischemic cerebral neovascularization |
| Q90115248 | Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia |
| Q53822322 | Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. |
| Q58419185 | Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment |
| Q36172162 | Impaired function of endothelial progenitor cells in children with primary systemic vasculitis |
| Q42067838 | Impairment of circulating endothelial progenitors in Down syndrome |
| Q54972391 | In the View of Endothelial Microparticles: Novel Perspectives for Diagnostic and Pharmacological Management of Cardiovascular Risk during Diabetes Distress. |
| Q35994205 | Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects |
| Q40923057 | Inflammatory environment and oxidized LDL convert circulating human proangiogenic cells into functional antigen-presenting cells |
| Q92666602 | Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice |
| Q36015213 | Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women |
| Q41811602 | Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect |
| Q64122946 | Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study |
| Q87077426 | Markers of endothelial damage and repair in Takayasu arteritis: are they associated with disease activity? |
| Q33886396 | Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. |
| Q33945532 | Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia |
| Q35968665 | Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis |
| Q39577348 | Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury |
| Q26783691 | Microparticles as Biomarkers of Blood Coagulation in Cancer |
| Q38118341 | Microparticles in health and disease. |
| Q54496757 | Mobilization of CD34+ KDR+ endothelial progenitor cells predicts target lesion revascularization. |
| Q38003931 | New vessels after stroke: postischemic neovascularization and regeneration |
| Q37842018 | Novel endothelial biomarkers: implications for periodontal disease and CVD. |
| Q37879909 | Obesity, the metabolic syndrome, and sexual dysfunction in men. |
| Q35586891 | Off-pump or minimized on-pump coronary surgery--initial experience with Circulating Endothelial Cells (CEC) as a supersensitive marker of tissue damage |
| Q99238190 | Orthohantavirus Pathogenesis and Cell Tropism |
| Q40617807 | Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1 |
| Q42872519 | Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. |
| Q40736650 | Preservation and enumeration of endothelial progenitor and endothelial cells from peripheral blood for clinical trials |
| Q39880030 | Retinoic acid-loaded polymeric nanoparticles enhance vascular regulation of neural stem cell survival and differentiation after ischaemia. |
| Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
| Q51690261 | Simulated temporary hypoxia triggers the release of CD31+/Annexin+ endothelial microparticles: A prospective pilot study in humans. |
| Q39590400 | Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. |
| Q58419163 | Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis |
| Q34417622 | The acute exposure effects of inhaled nickel nanoparticles on murine endothelial progenitor cells. |
| Q50880007 | The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo. |
| Q90777423 | The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension |
| Q60948025 | There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients |
| Q38165245 | Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers. |
| Q46168149 | Vascular dysfunction in patients with young β-thalassemia: relation to cardiovascular complications and subclinical atherosclerosis |
| Q38645654 | Vasculitis update: pathogenesis and biomarkers. |
| Q39243739 | Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins. |
Search more.